VIBRANTECH

Welcome to the Brand page for “VIBRANTECH”, which is offered here for Vaccines; biological preparations for the treatment of cancer; chemical preparations for pharmaceutical or medical purposes, for the treatment of cancer; cytostatics for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic radiopharmaceutical preparations; genetic identity tests comprised of reagents for medical purposes; hormones for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; radio-isotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive substances for use in nuclear medicine; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; tumor suppressing agents; mixed biological preparations for the prevention and treatment of infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “VIBRANTECH” is believed to be currently owned by “VIBRANT PHARMA LIMITED”.


Owner:
VIBRANT PHARMA LIMITED
Owner Details
Description:
Vaccines; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, for the treatment of cancer; Cytostatics for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic radiopharmaceutical preparations; Genetic identity tests comprised of reagents for medical purposes; Hormones for medical purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radioactive substances for use in nuclear medicine; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; Mixed biological preparations for the prevention and treatment of infectious diseases;
Categories: VACCINES